Health
Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option
PRINCETON, N.J., July 17, 2025--Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option
About this update from Bristol-myers Squibb Company
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1497,"height":206,"url":"https://media.zenfs.com/en/business-wire.com/fa565478394dff588ef4be9ece76e4a9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mEdNN2lPPtvvh9jHYXoREw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEzMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/fa565478394dff588ef4be9ece76e4a9","width":960,"height":132},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/ftti0r7m1uhRpFikeuCpig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zMzA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/fa565478394dff588ef4be9ece76e4a9","width":1200,"height":165}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/27da8cc7540587855883109563b6bea1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Fbqf8NF9ZrJ.mDlrqhiZHg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/27da8cc7540587855883109563b6bea1","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/F9tSzHVRDpp8H8hubj1IQg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/27da8cc7540587855883109563b6bea1","width":1024,"height":512}}},{"type":"text","content":"Eliquis 360 Support Program Now Offers Eliquis to Cash-Paying Patients at More than 40% Discount to Current List Price","length":118,"tagName":"p","attribs":{}},{"type":"text","content":"PRINCETON, N.J., July 17, 2025--(BUSINESS WIRE)--The Bristol Myers Squibb-Pfizer (BMS NYSE: BMY) – (Pfizer NYSE: PFE) Alliance today announced a new direct-to-patient option for purchasing Eliquis® (apixaban) via our Alliance’s patient resource Eliquis 360 Support. The offering provides an opportunity for uninsured, underinsured, or self-pay patients to significantly lower their out-of-pocket costs for this critical medicine. Eliquis is relied upon by millions of Americans daily and this program will provide a simple and transparent way to access it.","length":556,"tagName":"p"},{"type":"text","content":"Beginning September 8, eligible U.S. patients with an Eliquis prescription may purchase the medi...